Background: Parenteral nutrition (PN) is detrimental for the growth, development and survival of extremely premature babies. We have come a long way in providing nutrition to preterm babies in the ...

Protara Therapeutics (TARA) announced that data from THRIVE-1, a prospective, observational study evaluating the prevalence of choline ...

The efficacy of intradialytic parenteral nutrition (IDPN) in malnourished hemodialysis patients was studied. All patients at a large tertiary care institution who received IDPN for one month or ...

(NASDAQ: TARA) has announced significant findings from its THRIVE-1 study, which will be presented at the upcoming American Society for Parenteral and Enteral Nutrition (ASPEN) 2025 Nutrition ...

Purpose: The technical issues surrounding the use of albumin in parenteral nutrient (PN) solutions are reviewed. Summary: Five criteria have been suggested to determine which compounds are optimal ...

Belgium: A secondary analysis of the EPaNIC RCT (Early Parenteral Nutrition in Critically Ill Patients) has unveiled early ...

NEW YORK - Clinical-stage company Protara Therapeutics, Inc. (NASDAQ: TARA) has announced significant findings from its THRIVE-1 study, which will be presented at the upcoming American Society for ...